# Pentadecapeptide

> Pentadecapeptide refers to a class of 15-amino-acid peptides studied for gastrointestinal mucosal protection and broader systemic tissue repair, most notably represented by BPC-157. Research on these peptides originated from investigations into gastric juice-derived protective proteins. Preclinical studies suggest pentadecapeptides may support healing of gastric and intestinal lining injuries alongside broader musculoskeletal repair processes. Because of overlapping composition and mechanism with BPC-157, findings are often discussed interchangeably, though naming conventions vary between suppliers and researchers. Human clinical evidence remains limited.

- URL: https://www.lifeconverted.com/peptides/pentadecapeptide
- Also known as: PL 14736, BPC 15
- Primary category: Healing & Recovery
- Effectiveness rank: #22 in Healing & Recovery
- Evidence level: Emerging research
- Route: Subcutaneous (Also studied via oral administration in gastrointestinal-focused research due to reported stability in gastric fluid.)
- Dose range: 200-500 mcg
- Dose tiers: low 200 mcg; moderate 300 mcg; high 500 mcg
- Half-life: Estimated at under 4 hours, similar to related pentadecapeptides such as BPC-157
- Timing: Morning, or split AM/PM
- Cycle: 4 weeks on, 2-4 weeks off (Cycling patterns generally mirror those used for BPC-157 given the structural similarity.)
- Storage: Store lyophilized peptide frozen or refrigerated; reconstituted solution should be refrigerated and used within a few weeks.

## Mechanism of action

Pentadecapeptides are believed to interact with growth factor and nitric oxide signaling pathways to promote epithelial cell proliferation and mucosal defense. Preclinical work suggests they may help stabilize gastric lining integrity following chemical or mechanical injury. This mechanism is proposed to extend to connective tissue repair outside the gut through similar angiogenic pathways.

## Reported benefits

- Studied for gastric and intestinal mucosal protection
- Investigated for support of ulcer healing in animal models
- Explored for general connective tissue repair
- Reported anecdotally for digestive comfort support
- Studied for potential anti-inflammatory activity in GI tissue

## Reported side effects

- Gastrointestinal discomfort
- Injection site irritation when injected
- Headache
- Limited human data on long-term use

## Common protocols

- 300 mcg once daily, oral or subcutaneous, for 4 weeks in GI-focused research

## Stacking notes

Often used interchangeably with, or alongside, BPC-157 in GI-focused research protocols.

---

Educational information only, not medical advice. Full disclaimer: https://www.lifeconverted.com/disclaimer